Wei-Xiang Qi

13PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyLandscape ecologyPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial.

|May 04, 2026
RNI Precision Trial Protocol: Optimization of Regional Node Irradiation for Sentinel Lymph Node-positive Breast Cancer Omitting Axillary Dissection Based on Clinical and Genomic Risk Assessment: A Prospective Clinical Trial.

|Feb 08, 2026
Whole Heart Dose Parameters Predict Severe Arrhythmias After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Competing Risk Analysis of 358 Patients.

Wei-Xiang Qi, Haiping Zhang, Xunmei Yang

|Oct 16, 2025
Retrospective Analysis of CT-based Habitat Analysis for Predicting pCR and Survival of ESCC Treated by Neoadjuvant Chemoradiotherapy and Esophagectomy.

Shujun Zhang, Wei-Xiang Qi, Feng Wang

|Sep 21, 2025
Sparing lymphocytes during preoperative adjuvant radiotherapy for oesophageal squamous cell carcinoma (SPARE): protocol for an open-label, randomised controlled trial.

Wei-Xiang Qi, Shuyan Li, Huan Li

|May 16, 2025
One-week regimen for postoperative regional irradiation in breast cancer: the ARROW trial protocol.

Jinrong Xie, Siyue Zheng, Wei-Xiang Qi

Pageof 3

Frequent Collaborators

3 joint publications

Shengguang Zhao

3 joint publications

Jiayi Chen

2 joint publications

Cheng Xu

2 joint publications

Jiayi Chen